The role of genetic risk factors and immune response on NVU function in post-TBI cognitive impairment

Active Project Grant Awarded Last action

Award ID
HT94252411046
Recipient
Awarding agency
Obligated
$6,214,900

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 50% complete
Place of performance
San Diego, CA 92121, USA

Award details come from USAspending.gov.

About this award

This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over a 4-year period from November 1, 2024 to October 31, 2028. The research aims to enhance understanding of fundamental biological processes and develop potential therapeutic approaches for this medical condition affecting military personnel and the general public.

Quick answers

Who received award HT94252411046?

HT94252411046 was awarded to The Scintillon Institute by Defense Health Agency (Department of Defense) on November 1, 2024.

How much is award HT94252411046 worth?

$6,214,900 has been obligated on HT94252411046.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award